Fabino Life Sciences
Fabino Life Sciences Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Fabino Life Sciences
Start SIPFabino Life Sciences Investment Rating
-
Master Rating:
-
Fabino Life Sciences has an operating revenue of Rs. 18.13 Cr. on a trailing 12-month basis. An annual revenue de-growth of -20% needs improvement, Pre-tax margin of 0% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 10%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 18 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 95 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Mar 2022 |
|---|---|---|
| Total Revenue Annual Cr | 3 | 4 |
| Operating Expenses Annual Cr | 3 | 4 |
| Operating Profit Annual in Cr | 0 | 0 |
| Depreciation Cr | 0 | 0 |
| Interest Annual Cr | 0 | 0 |
| Tax Annual Cr | 0 | 0 |
| Net Profit Annual Cr | 0 | 0 |
Fabino Life Sciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 4
- Bearish Moving Average
- ___
- 10
- 20 Day
- ₹29.54
- 50 Day
- ₹30.2
- 100 Day
- ₹30.64
- 200 Day
- ₹
- 20 Day
- ₹29.85
- 50 Day
- ₹30.8
- 100 Day
- ₹29.85
- 200 Day
- ₹
Fabino Life Sciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹29.5 |
| Second Resistance | ₹29.5 |
| Third Resistance | ₹29.5 |
| RSI | 49.07 |
| MFI | 31.48 |
| MACD Single Line | -0.55 |
| MACD | -0.54 |
| Support | |
|---|---|
| First Resistance | ₹29.5 |
| Second Resistance | ₹29.5 |
| Third Resistance | ₹29.5 |
Fabino Life Sciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 3,000 | 300,000 | 100 |
| Week | 3,000 | 300,000 | 100 |
| 1 Month | |||
| 6 Month | 1,065 | 96,775 | 90.91 |
Fabino Life Sciences Result Highlights
Fabino Life Sciences Synopsis
BSE-Medical-Biomed/Biotech
Fabino Life Sciences belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 3.36 Cr. and Equity Capital is Rs. 2.10 Cr. for the Year ended 31/03/2023. Fabino Life Sciences Ltd. is a Public Limited Listed company incorporated on 27/10/2011 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L24100HR2011PLC114093 and registration number is 226781.| Market Cap | 0 |
| Sales | 3 |
| Shares in Float | 0.09 |
| No of funds | |
| Yield |
| Book Value | 1.51 |
| U/D Vol ratio | 0.5 |
| LTDebt / Equity | 10 |
| Alpha | 0.04 |
| Beta | -0.33 |
Fabino Life Sciences
| Owner Name | Mar-23 | Sep-22 |
|---|---|---|
| Promoters | 56.82% | 56.82% |
| Individual Investors | 28.33% | 28.32% |
| Others | 14.85% | 14.86% |
Fabino Life Sciences Management
| Name | Designation |
|---|---|
| Mr. Atul Kumar Jain | Executive Director |
| Mr. Aditya Mahavir Jain | Non Executive Director |
| Mr. Arihant Jain | Non Executive Director |
| Mr. Kuldeep Singh Solanki | Independent Director |
| Mrs. Tesu Alakh | Independent Director |
| Mr. Gagan Gupta | Independent Director |
| Mr. Sumit Malik | Non Executive Director |
Fabino Life Sciences Forecast
Price Estimates
Fabino Life Sciences Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-30 | Audited Results | |
| 2023-05-24 | Audited Results | |
| 2022-11-09 | Half Yearly Results | |
| 2022-05-24 | Audited Results |
- Company Name
- CMP
- Chg(%)
- Adani Ports
- 831
- 1.6
- Tech Mahindra
- 1292
- 1.4
- Dr Reddys Labs
- 5669
- 1.0
- Asian Paints
- 3244
- 0.9
- Bharti Airtel
- 918
- 0.8
- Company Name
- CMP
- Chg(%)
Fabino Life Sciences FAQs
What is Share Price of Fabino Life Sciences ?
Fabino Life Sciences share price is ₹29 As on 21 September, 2023 | 17:33
What is the Market Cap of Fabino Life Sciences ?
The Market Cap of Fabino Life Sciences is ₹6.2 Cr As on 21 September, 2023 | 17:33
What is the P/E ratio of Fabino Life Sciences ?
The P/E ratio of Fabino Life Sciences is As on 21 September, 2023 | 17:33
What is the PB ratio of Fabino Life Sciences ?
The PB ratio of Fabino Life Sciences is 1.5 As on 21 September, 2023 | 17:33